Condition: Aortic Valve Stenosis · Sponsor: Valve Medical
The main objective of this study is to evaluate the feasibility and safety of the GEMINUS system in patients with severe symptomatic aortic stenosis. This is a prospective, open label, multicentre, single arm, first in human clinical study. Clinical follow up for all patients will be performed at 30 days, 6 months, 1, 2, 3, 4 and 5 years post-implantation
This description comes directly from the study's public registry record.
Brenda Koltun Reuven · 972-542666688 · brendak@medinol.com
Always discuss trial participation with your own doctor first.
| Rabin Medical Center | Petah Tikva, Israel | Recruiting |
| Tel Aviv Sourasly Medical Center | Tel Aviv, Israel | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05909748